World Lifestyler
  • Art & Culture
    • Architecture
    • Art & Exhibitions
    • Books
    • Design
    • Film & Music
  • Competitions
    • Dining Experiences
    • Hotel Stays
    • Luxury Experiences
    • Product Giveaways
    • Reader Exclusives
    • Travel Giveaways
  • Food & Drink
    • Chefs
    • Coffee Culture
    • Food Destinations
    • Recipes
    • Restaurants
    • Wine & Spirits
  • Lifestyle
    • Design
    • Fashion
    • Health & Wellbeing
    • Homes & Property
    • Love & Romance
  • People
    • Creatives
    • Entrepreneurs
    • Icons
    • Interviews
    • Profiles
    • Rising Talent
  • Travel
    • Adventure & Experience Travel
    • City Guides
    • Destinations
    • Hotels
    • Secret Spots
    • Travel Trends
  • Art & Culture
    • Architecture
    • Art & Exhibitions
    • Books
    • Design
    • Film & Music
  • Competitions
    • Dining Experiences
    • Hotel Stays
    • Luxury Experiences
    • Product Giveaways
    • Reader Exclusives
    • Travel Giveaways
  • Food & Drink
    • Chefs
    • Coffee Culture
    • Food Destinations
    • Recipes
    • Restaurants
    • Wine & Spirits
  • Lifestyle
    • Design
    • Fashion
    • Health & Wellbeing
    • Homes & Property
    • Love & Romance
  • People
    • Creatives
    • Entrepreneurs
    • Icons
    • Interviews
    • Profiles
    • Rising Talent
  • Travel
    • Adventure & Experience Travel
    • City Guides
    • Destinations
    • Hotels
    • Secret Spots
    • Travel Trends
No Result
View All Result
WORLD LIFESTYLER
No Result
View All Result
Home Press Releases Press Releases - Lifestyle

Hanon Systems Publishes White Paper on Next-Generation PFAS-Free Natural Refrigerant Technologies

Cision PR Newswire by Cision PR Newswire
July 6, 2026
in Press Releases - Lifestyle
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

SEOUL, South Korea, July 5, 2026 /PRNewswire/ — Hanon Systems (KS:018880), a leading global automotive thermal management solutions provider and a member of Hankook & Company Group, has published a white paper highlighting the company’s next-generation PFAS-free natural refrigerant technologies.

The paper highlights the environmental limitations of conventional fluorinated refrigerants and outlines a roadmap toward natural refrigerant technologies as a sustainable alternative. It comes at a time when the automotive industry is increasingly focused on long-term environmental sustainability. Widely used refrigerants like R1234yf can transform into trifluoroacetic acid (TFA), a long-lasting environmental contaminant, driving the need for viable long-term solutions.

To address these challenges, Hanon Systems presents its progress in developing natural refrigerant technologies based on carbon dioxide (R744) and propane (R290). Building on the successful introduction to the market of its R744-based technology – including electric compressors, refrigerant valves, accumulator/internal heat exchangers and gas coolers – already deployed in more than one million vehicles, the company is also advancing R290-based solutions as a PFAS-free alternative for future mobility.

“The publication of this white paper reflects Hanon Systems’ strong technological capacities and its commitment to proactively addressing evolving global regulations,” said Vice Chairman and Chief Executive Officer of Hanon Systems, Soo Il Lee. “Natural refrigerant technologies offer effective solutions to the PFAS related and environmental challenges facing our industry. We will continue to collaborate closely with global automakers to advance sustainable mobility solutions.“

The document is available for download on hanonsystems.com.

About Hanon Systems

Hanon Systems, founded in 1986, is a global leader in thermal management solutions. In January 2025, it became a subsidiary of Hankook & Company Group. Its offering includes a wide range of solutions in the areas of heating, ventilation and air conditioning, powertrain cooling, compressor, fluid transport, and electronics and fluid pressure. The company currently operates 50 manufacturing sites and three regional innovation centers and employs more than 20,000 people across 21 countries. To learn more, visit hanonsystems.com.

Follow Hanon Systems:

LinkedIn: https://www.linkedin.com/company/hanonsystems

YouTube: https://www.youtube.com/channel/UC6bSZ7NMg7LPhXDyTOMwebQ/feed

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/hanon-systems-publishes-white-paper-on-next-generation-pfas-free-natural-refrigerant-technologies-302818069.html

SOURCE Hanon Systems

Cision PR Newswire

Cision PR Newswire

Related Posts

MGI Tech and Shanghai AI Laboratory Unveil ProtoPilot and BioLab Bench, Pioneering Physical AI for Life Sciences

July 6, 2026

Segway Powersports Opens First GCC Flagship Store in Riyadh with Launch of the Super Villain SX20T

July 6, 2026

Ascletis Submits Two IND Applications to the U.S. FDA for the Treatment of Obesity: ASC36 Once-Monthly Injection, a Peptide Amylin Receptor Agonist, and ASC36_35 FDC Once-Monthly Injection, a Co-Formulation of ASC36 Plus Peptide GLP-1R/GIPR Agonist ASC35

July 6, 2026

Hyundai Motor Brings Atlas Humanoid Robot to FIFA World Cup 2026™ in First-Ever Live Match Environment Robotics Integration

July 6, 2026

Celebrating Independence Day: Freedom to Enjoy Every Summer Moment With VARON Oxygen Concentrator Solutions

July 5, 2026

Monster Energy Athletes Claim Victories on Day 2 of X Games Chiba 2026

July 5, 2026

Popular News

  • MGI Tech and Shanghai AI Laboratory Unveil ProtoPilot and BioLab Bench, Pioneering Physical AI for Life Sciences

    0 shares
    Share 0 Tweet 0
  • Segway Powersports Opens First GCC Flagship Store in Riyadh with Launch of the Super Villain SX20T

    0 shares
    Share 0 Tweet 0
  • Hanon Systems Publishes White Paper on Next-Generation PFAS-Free Natural Refrigerant Technologies

    0 shares
    Share 0 Tweet 0
  • Ascletis Submits Two IND Applications to the U.S. FDA for the Treatment of Obesity: ASC36 Once-Monthly Injection, a Peptide Amylin Receptor Agonist, and ASC36_35 FDC Once-Monthly Injection, a Co-Formulation of ASC36 Plus Peptide GLP-1R/GIPR Agonist ASC35

    0 shares
    Share 0 Tweet 0
  • PingPong Payments Secures In-Principle Approval for a Capital Markets Services Licence

    0 shares
    Share 0 Tweet 0

About & Contact

  • About Us
  • Branding Style Guide
  • Contact Us
  • Help Centre
  • Media Kit
  • Site Map

Explore Content

  • Events
  • Newsletter
  • Press Releases
  • Topics

Legal & Privacy

  • Advertiser & Partner Policy
  • Communications & Newsletter Policy
  • Contributor Agreement
  • Copyright Policy
  • Privacy Policy
  • Prohibited Content Policy
  • Terms of Service

Tiny Media Brands

  • Silicon Valleys Journal
  • The AI Journal
  • The City Banker
  • The Wall Street Banker
  • World Lifestyler

© 2025 World Lifestyler

No Result
View All Result
  • Home

© 2025 World Lifestyler